Market Cap 135.29M
Revenue (ttm) 0.00
Net Income (ttm) -12.55M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 269,600
Avg Vol 215,690
Day's Range N/A - N/A
Shares Out 32.92M
Stochastic %K 35%
Beta 0.66
Analysts Strong Sell
Price Target $10.33

Company Profile

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs include the development of a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company's vaccine programs include the development of a vaccine against breast cancer, initially focused on triple negative breast cancer (TNBC), the...

Industry: Biotechnology
Sector: Healthcare
Phone: 408 708 9808
Address:
3150 Almaden Expressway, Suite 250, San Jose, United States
L17X
L17X Nov. 16 at 11:15 AM
$ANIX Shared my full thesis today: The recent jump in Anixa looks heavily driven by the Buy rating from D. Boral Capital. https://l17x.beehiiv.com/p/anixa-bioscienes-theses-11-16-25
0 · Reply
aletz
aletz Nov. 13 at 3:26 PM
$ANIX https://www.biostockinfo.com/biotech-catalyst-ai-scanner-november-wk3/ ANIX is on the list again! this week, it moved to 3rd place. I have no control over the ranking, it's machine learning and AI's job lol, IFRX and GLTO from last week's top 15 exploded. ANIX seems to be showing a good momentum.
0 · Reply
ChessHere
ChessHere Nov. 12 at 9:16 PM
$ANIX Frank - I just read the SeekingAlpha article - sadly it aligns with my comments below. While I am optimistic, I will reserve judgement until I see the December at which time I can make a better informed decision to stay or pull out - however, reading between the lines of Amit's interview with WatchTower Research there was a lot of wiggle room on next steps, timing, and the cost to do a fulsome P2 trial. Dammit, I hate being pessimistic with how things are starting to look...
1 · Reply
ChessHere
ChessHere Nov. 12 at 7:27 PM
$ANIX BTW - they've been pushing patent protection almost every month or so for as long as I can remember - doesn't mean anything if they can't get to market. Remember when the screamed patent protection on their covid research - sp went to over $8 only to fizzle out within a week, including their vaunted covid solution that went absolutely nowhere.
3 · Reply
ChessHere
ChessHere Nov. 12 at 7:21 PM
$ANIX can you SAY shares dilution - what happened to partnering with big pharma to offset costs???
0 · Reply
ChessHere
ChessHere Nov. 12 at 7:15 PM
$ANIX listened to the fireside chat audio. OMG - absolutely nothing other that words like "spectacular", "we're very excited", "results exceeded our expectations" blah, blah, blah. Don't get me wrong, I have well over 6 figures in this company going all the way back to Itus and Ccheck - BUT I have been hearing the same words for the past 7 years, including with their failed Ccheck program. And worse yet, the next trial is just around the corner but now the breast cancer vaccine is SOMETIME next year (oh wait, he said eventually - what the hell does that mean). While Amit gets paid millions, he keep pushing timelines out (now up to 5-7 years before it gets to market). I must say, given how much I want them to succeed, I am seriously considering pulling out. So dam tired hearing him say we are hoping to partner while saying no guarantees, not to mention how he lauds his capital structure only to follow it up with we will need lots more cash from wall street to continue in the future.
1 · Reply
frankparch
frankparch Nov. 12 at 5:12 PM
$ANIX does anyone have access to this? https://seekingalpha.com/article/4842535-anixa-biosciences-hard-to-justify-optimism-with-an-upcoming-phase-1-readout
1 · Reply
TimRegan_WTR
TimRegan_WTR Nov. 12 at 4:28 PM
0 · Reply
research_WTR
research_WTR Nov. 12 at 3:24 PM
We're excited to share that our most recent Fireside Chat with Anixa Biosciences, Inc. Chairman & CEO Dr. Amit Kumar is now available on-demand! For those who may have missed the live broadcast or had any technical issues with the stream, please use the link here for the replay: https://us06web.zoom.us/webinar/register/WN_LiTi8dfgRXuVPaFYq5E7OQ $ANIX #AnixaBiosciences #BreastCancer #Vaccine #Healthcare #Trials #FiresideChat #SmallCap #Stocks #Investing #EquityResearch #CapitalMarkets
0 · Reply
Kher33
Kher33 Nov. 12 at 2:28 PM
$ANIX https://ir.anixa.com/press-releases/detail/1104
0 · Reply
Latest News on ANIX
Anixa Biosciences: Oncology Platform With Asymmetric Upside

Jul 15, 2025, 3:49 PM EDT - 4 months ago

Anixa Biosciences: Oncology Platform With Asymmetric Upside


Anixa Biosciences to Host an Investor Webcast on June 26, 2025

Jun 20, 2025, 7:30 AM EDT - 5 months ago

Anixa Biosciences to Host an Investor Webcast on June 26, 2025


Anixa Biosciences CEO Provides Letter to Shareholders

Jan 21, 2025, 8:30 AM EST - 10 months ago

Anixa Biosciences CEO Provides Letter to Shareholders


L17X
L17X Nov. 16 at 11:15 AM
$ANIX Shared my full thesis today: The recent jump in Anixa looks heavily driven by the Buy rating from D. Boral Capital. https://l17x.beehiiv.com/p/anixa-bioscienes-theses-11-16-25
0 · Reply
aletz
aletz Nov. 13 at 3:26 PM
$ANIX https://www.biostockinfo.com/biotech-catalyst-ai-scanner-november-wk3/ ANIX is on the list again! this week, it moved to 3rd place. I have no control over the ranking, it's machine learning and AI's job lol, IFRX and GLTO from last week's top 15 exploded. ANIX seems to be showing a good momentum.
0 · Reply
ChessHere
ChessHere Nov. 12 at 9:16 PM
$ANIX Frank - I just read the SeekingAlpha article - sadly it aligns with my comments below. While I am optimistic, I will reserve judgement until I see the December at which time I can make a better informed decision to stay or pull out - however, reading between the lines of Amit's interview with WatchTower Research there was a lot of wiggle room on next steps, timing, and the cost to do a fulsome P2 trial. Dammit, I hate being pessimistic with how things are starting to look...
1 · Reply
ChessHere
ChessHere Nov. 12 at 7:27 PM
$ANIX BTW - they've been pushing patent protection almost every month or so for as long as I can remember - doesn't mean anything if they can't get to market. Remember when the screamed patent protection on their covid research - sp went to over $8 only to fizzle out within a week, including their vaunted covid solution that went absolutely nowhere.
3 · Reply
ChessHere
ChessHere Nov. 12 at 7:21 PM
$ANIX can you SAY shares dilution - what happened to partnering with big pharma to offset costs???
0 · Reply
ChessHere
ChessHere Nov. 12 at 7:15 PM
$ANIX listened to the fireside chat audio. OMG - absolutely nothing other that words like "spectacular", "we're very excited", "results exceeded our expectations" blah, blah, blah. Don't get me wrong, I have well over 6 figures in this company going all the way back to Itus and Ccheck - BUT I have been hearing the same words for the past 7 years, including with their failed Ccheck program. And worse yet, the next trial is just around the corner but now the breast cancer vaccine is SOMETIME next year (oh wait, he said eventually - what the hell does that mean). While Amit gets paid millions, he keep pushing timelines out (now up to 5-7 years before it gets to market). I must say, given how much I want them to succeed, I am seriously considering pulling out. So dam tired hearing him say we are hoping to partner while saying no guarantees, not to mention how he lauds his capital structure only to follow it up with we will need lots more cash from wall street to continue in the future.
1 · Reply
frankparch
frankparch Nov. 12 at 5:12 PM
$ANIX does anyone have access to this? https://seekingalpha.com/article/4842535-anixa-biosciences-hard-to-justify-optimism-with-an-upcoming-phase-1-readout
1 · Reply
TimRegan_WTR
TimRegan_WTR Nov. 12 at 4:28 PM
0 · Reply
research_WTR
research_WTR Nov. 12 at 3:24 PM
We're excited to share that our most recent Fireside Chat with Anixa Biosciences, Inc. Chairman & CEO Dr. Amit Kumar is now available on-demand! For those who may have missed the live broadcast or had any technical issues with the stream, please use the link here for the replay: https://us06web.zoom.us/webinar/register/WN_LiTi8dfgRXuVPaFYq5E7OQ $ANIX #AnixaBiosciences #BreastCancer #Vaccine #Healthcare #Trials #FiresideChat #SmallCap #Stocks #Investing #EquityResearch #CapitalMarkets
0 · Reply
Kher33
Kher33 Nov. 12 at 2:28 PM
$ANIX https://ir.anixa.com/press-releases/detail/1104
0 · Reply
Pretzel34
Pretzel34 Nov. 12 at 2:19 PM
$ANIX I see the company now has patent protection for their breast cancer vaccine into the 2040's. With the Keytruda patent expiring in 2028, Im curious if Merck would want to partner with Anixa on subsequent trials. If Keytruda is more effective when combined with the vaccine technology i would think they would want that in place before sales drop off after current patent expiration. Just my own ramblings here.....
0 · Reply
ChessHere
ChessHere Nov. 11 at 11:53 PM
$ANIX absolutely... wasted my entire afternoon thing it was just delayed a bit
1 · Reply
snuzuluz
snuzuluz Nov. 11 at 9:43 PM
$ANIX The lack of a press release explaining the Fireside Chat delay/cancellation disrespects shareholders. Not a good look! 👀
0 · Reply
ChessHere
ChessHere Nov. 11 at 7:48 PM
$ANIX has anyone gotten into fireside chat? All i get is waiting for host to start...
2 · Reply
bioinvestorrr
bioinvestorrr Nov. 11 at 3:50 PM
$ANIX beginning of run up into december news?
0 · Reply
aletz
aletz Nov. 6 at 9:36 PM
$ANIX https://www.biostockinfo.com/biotech-catalyst-ai-scanner-november-wk2/ #14 on the list
0 · Reply
jshdn
jshdn Nov. 5 at 10:14 PM
$ANIX does anyone have a sense of what the odds might be of a successful phase two a successful phase three and ultimately approval ?
1 · Reply
Kher33
Kher33 Nov. 5 at 2:00 PM
$ANIX https://ir.anixa.com/news/detail/1102
0 · Reply
TimRegan_WTR
TimRegan_WTR Nov. 4 at 7:49 PM
0 · Reply
research_WTR
research_WTR Nov. 4 at 6:51 PM
Please join Robert Sassoon for a fireside chat with Anixa Biosciences, Inc. Chairman & CEO Dr. Amit Kumar, on Tuesday, November 11, 2025, at 2:00 pm ET. Register below! https://us06web.zoom.us/webinar/register/5817621959008/WN_zLl3VvR4TRyikSX7QdSoMQ $ANIX #AnixaBiosciences #Healthcare #FiresideChat #SmallCap #Stocks #Investing
0 · Reply
justiceforb_85
justiceforb_85 Oct. 28 at 8:27 PM
$ANIX December breast cancer vaccine update is around the corner!
0 · Reply
loginname
loginname Oct. 28 at 4:28 AM
$ANIX there are many bid at 4 the price can’t easy down from 4 i am waiting for 3.8 but that never come next week, $ANIX will have Spartan capital sccurities if you want to bet just in this week, if you want to invest waiting 2-4 days after Spartan.
0 · Reply